Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma

by palligoelme@gmail.com | Dec 16, 2025 | Clinical Trials

​ Conditions: Phase 2; Zanzalintinib; Pembrolizumab; Advanced/Metastatic; Soft-Tissue Sarcoma Interventions: Drug: Zanzalintinib; Drug: Pembrolizumab Sponsors: M.D. Anderson Cancer Center; Exelixis Not yet recruiting Conditions: Phase 2; Zanzalintinib; Pembrolizumab;...

Atelocollagen ＆ Hyaluronic Acid Correlation With Enhancement of Rotator Cuff Healing: Synergistic Effect?

by palligoelme@gmail.com | Dec 16, 2025 | Clinical Trials

​ Conditions: Rotator Cuff Tear Interventions: Procedure: Atelo collagen injection; Procedure: Hyaluronic acid injection Sponsors: Hallym University Dongtan Sacred Heart Hospital; Ministry of Science and ICT, Republic of Korea Active, not recruiting Conditions:...

Sarcopenia and NMIBC Prognosis Study

by palligoelme@gmail.com | Dec 16, 2025 | Clinical Trials

​ Conditions: Bladder Cancer Cell Transitional Sponsors: General Hospital Sveti Duh Not yet recruiting Conditions: Bladder Cancer Cell Transitional Sponsors: General Hospital Sveti Duh Not yet recruiting 

P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

by palligoelme@gmail.com | Dec 16, 2025 | Clinical Trials

​ Conditions: Helicobacter Pylori Infection Interventions: Other: Doctors prescribe Helicobacter pylori treatment regimens for patients based on current guidelines and consensus statements, tailored to individual circumstances，not involve any intervention procedures...

Enhanced Ward Rounds and Communication for Pre-procedural Anxiety in GI Endoscopy Patients

by palligoelme@gmail.com | Dec 16, 2025 | Clinical Trials

​ Conditions: Anxiety; Depression Disorders; Sleep Wake Disorders; Gastrointestinal Diseases; Preoperative Anxiety Interventions: Behavioral: Enhanced Ward-Round Frequency With Standardized Communication; Behavioral: Usual Care Ward Rounds (2/day) Sponsors: LanZhou...